Date: Tue, 07 Dec 1999 10:43:59 -0600
From: Peter Khaled <email@example.com>
Subject: Revolving Door - Updated list - FYI
David W. Beier . . .former head of Government Affairs for
Genentech, Inc., . . .now chief domestic policy advisor to Al
Gore, Vice President of the United States.
Linda J. Fisher . . .former Assistant Administrator of the
United States Environmental Protection Agency's Office of
Pollution Prevention, Pesticides, and Toxic Substances, . . .now
Vice President of Government and Public Affairs for Monsanto
Michael A. Friedman, M.D. . . former acting commissioner of
the United States Food and Drug Administration (FDA)
Department of Health and Human Services . . .now senior
vice-president for clinical affairs at G. D. Searle & Co., a
pharmaceutical division of Monsanto Corporation.
L. Val Giddings . . . former biotechnology regulator and
(biosafety) negotiator at the United States Department of
Agriculture (USDA/APHIS), . . .now Vice President for Food &
Agriculture of the Biotechnology Industry Organization (BIO).
Marcia Hale . . . former assistant to the President of the
United States and director for intergovernmental affairs, . .
.now Director of International Government Affairs for Monsanto
Michael (Mickey) Kantor. . . former Secretary of the United
States Department of Commerce and former Trade
Representative of the United States, . . .now member of the
board of directors of Monsanto Corporation.
Josh King . . . former director of production for White House
events, . . . now director of global communication in the
Washington, D.C. office of Monsanto Corporation.
Terry Medley . . . former administrator of the Animal and
Plant Health Inspection Service (APHIS) of the United States
Department of Agriculture, former chair and vice-chair of the
United States Department of Agriculture Biotechnology Council,
former member of the U.S. Food and Drug Administration (FDA)
food advisory committee, . . . and now Director of Regulatory
and External Affairs of Dupont Corporation's Agricultural
Margaret Miller . . . former chemical laboratory supervisor for
Monsanto, . . .now Deputy Director of Human Food Safety and
Consultative Services, New Animal Drug Evaluation Office,
Center for Veterinary Medicine in the United States Food and
Drug Administration (FDA).*
Michael Phillips . . . recently with the National Academy of
Science Board on Agriculture . . . now head of regulatory affairs
for the Biotechnology Industry Organization.
William D. Ruckelshaus . . . former chief administrator of the
United States Environmental Protection Agency (USEPA), . .
.now (and for the past 12 years) a member of the board of
directors of Monsanto Corporation.
Michael Taylor . . . former legal advisor to the United States
Food and Drug Administration (FDA)'s Bureau of Medical
Devices and Bureau of Foods, later executive assistant to the
Commissioner of the FDA, . . . still later a partner at the law
firm of King & Spaulding where he supervised a nine-lawyer
group whose clients included Monsanto Agricultural Company, .
. . still later Deputy Commissioner for Policy at the United
States Food and Drug Administration, . . . and later with the
law firm of King & Spaulding. . . . now head of the
Washington, D.C. office of Monsanto Corporation.*
Lidia Watrud . . . former microbial biotechnology researcher at
Monsanto Corporation in St. Louis, Missouri, . . .now with the
United States Environmental Protection Agency Environmental
Effects Laboratory, Western Ecology Division.
Jack Watson. . .former chief of staff to the President of the
United States, Jimmy Carter, . . .now a staff lawyer with
Monsanto Corporation in Washington, D.C.
Clayton K. Yeutter . . . former Secretary of the U.S.
Department of Agriculture, former U.S. Trade Representative
(who led the U.S. team in negotiating the U.S. Canada Free
Trade Agreement and helped launch the Uruguay Round of the
GATT negotiations), now a member of the board of directors of
Mycogen Corporation, whose majority owner is Dow
AgroSciences, a wholly owned subsidiary of The Dow Chemical
Larry Zeph . . . former biologist in the Office of Prevention,
Pesticides, and Toxic Substances, U.S. Environmental
Protection Agency, . . . now Regulatory Science Manager at
Pioneer Hi-Bred International.
*Margaret Miller, Michael Taylor, and Suzanne Sechen (an FDA
"primary reviewer for all rbST and other dairy drug production applications"
) were the subjects of a U.S. General Accounting Office (GAO) investigation in
1994 for their role in the U.S. Food and Drug Administration's approval of
Posilac, Monsanto Corporation's formulation of recombinant bovine growth
hormone (rbST or rBGH). The GAO Office found "no conflicting financial
interests with respect to the drug's approval" and only "one minor deviation from
now superseded FDA regulations". (Quotations are from the 1994 GAO